Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Follicular Lymphoma. A Combined Analysis on Behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains the only potentially curative treatment option for relapsed follicular lymphoma (FL), yet questions remain on the optimal timing. We have analysed long-term outcomes and associated factors among recipients of allo-HCT...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer
Asıl Yazarlar: Sureda, A., Zhang, M.-J., Dreger, P., Carreras, J., Fenske, T., Finel, H., Schouten, H., Montoto, S., Robinson, S., Smith, S. M., Boumedil, A., Hamadani, M., Pasquini, M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946312/
https://ncbi.nlm.nih.gov/pubmed/29424927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31264
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller